Clinical trial
Cardioprotective Effects of Sodium Creatine Phosphate in Valve Surgery: A Prospective Randomized Controlled Study
NCT03186053 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences, Fuwai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardioprotective Effects of Sodium Creatine Phosphate in Valve Surgery: A Prospective Randomized Controlled Study
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 15, 2017
- Completion date
- December 31, 2018
- Enrollment
- 250 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.